![Adam Knight](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adam Knight
Consultor / Asesor en
Perceptive Advisors (Private Equity)
.
Perfil
Adam Knight was the founder of Neuron23, Inc. which was founded in 2017, where he held the title of Chief Business Officer from 2017 to 2023.
Currently, he is an Advisor at Perceptive Advisors (Private Equity) since 2022 and a Strategic Advisor at Soda Health, Inc. since 2021.
He previously worked as a Scientific Advisor at eFFECTOR Therapeutics, Inc. Dr. Knight received his doctorate degree from the University of Cambridge in 2015, his graduate degree from The University of Alabama School of Medicine in 2011, and his undergraduate degree from The University of Alabama School of Medicine in 2009.
Cargos activos de Adam Knight
| Empresas | Cargo | Inicio |
|---|---|---|
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Consultor / Asesor | 01/02/2022 |
Soda Health, Inc.
 Soda Health, Inc. Internet Software/ServicesTechnology Services Operates as a healthcare technology platform | Consultor / Asesor | 01/04/2021 |
Antiguos cargos conocidos de Adam Knight.
| Empresas | Cargo | Fin |
|---|---|---|
Neuron23, Inc.
 Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Fundador | 22/08/2023 |
| EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formación de Adam Knight.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
95
Relaciones de 1er grado
6
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama School of Medicine
 The University of Alabama School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Finance |
Neuron23, Inc.
Neuron23, Inc. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Soda Health, Inc.
Soda Health, Inc. Internet Software/ServicesTechnology Services Operates as a healthcare technology platform | Technology Services |
- Bolsa de valores
- Insiders
- Adam Knight
